| pubmed-article:1588234 | pubmed:abstractText | The use of Ethibloc must be contemplated as a first-intention treatment for venous malformations of the face. This sclerosing agent has transformed the functional, esthetic and psychological prognosis for these vascular malformations. | lld:pubmed |
